InnovationRx: Amtitrust Regulators OK Oracle-Cerner Deal; Plus, Covid Vaccine Mixing And Matching
forbes.com
news
2022-06-01 23:11:42

InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Antitrust regulators, including the European Commission, have greenlit Oracle's acquisition of healthcare technology company Cerner, the company said Wednesday afternoon. Oracle first announced its plans to buy Cerner for $28.3 billion with an all cash tender offer of $95 a share in December 2021, as the database and cloud infrastructure company looks to expand its footprint in the healthcare sector. Cerner shares closed at $94.
